Demant Operating Income 2012-2024 | WILYY
Demant annual/quarterly operating income history and growth rate from 2012 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Demant operating income for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Demant operating income for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Demant annual operating income for 2024 was $0.657B, a 9.01% increase from 2023.
- Demant annual operating income for 2023 was $0.602B, a 32.63% increase from 2022.
- Demant annual operating income for 2022 was $0.454B, a 17.15% decline from 2021.
|
Demant Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $657 |
| 2023 | $602 |
| 2022 | $454 |
| 2021 | $548 |
| 2020 | $234 |
| 2019 | $322 |
| 2018 | $401 |
| 2017 | $355 |
| 2016 | $289 |
| 2015 | $280 |
| 2014 | $1,666 |
| 2013 | $318 |
| 2012 | $284 |
| 2011 | $318 |
|
Demant Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2016-06-30 | |
| 2015-12-31 | |
| 2014-06-30 | |
| 2013-12-31 | |
| 2013-06-30 | |
| 2012-12-31 | |
| 2012-06-30 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.346B | $3.252B |
| Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company's business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.106B | 26.06 |
| EssilorLuxottica (ESLOY) | France | $168.548B | 0.00 |
| Boston Scientific (BSX) | United States | $150.853B | 34.49 |
| Stryker (SYK) | United States | $137.722B | 27.34 |
| Medtronic (MDT) | Ireland | $123.497B | 17.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.264B | 0.00 |
| Agilent Technologies (A) | United States | $40.971B | 26.52 |
| ResMed (RMD) | United States | $35.713B | 24.72 |
| GE HealthCare Technologies (GEHC) | United States | $32.173B | 15.39 |
| Koninklijke Philips (PHG) | Netherlands | $26.943B | 17.60 |
| Insulet (PODD) | United States | $23.075B | 71.62 |
| Terumo (TRUMY) | Japan | $22.623B | 25.47 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.567B | 10.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.901B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Baxter (BAX) | United States | $9.135B | 7.37 |
| Bio-Rad Laboratories (BIO) | United States | $8.202B | 29.49 |
| Lantheus Holdings (LNTH) | United States | $3.481B | 10.61 |
| Haemonetics (HAE) | United States | $3.479B | 15.48 |
| ICU Medical (ICUI) | United States | $3.321B | 21.08 |
| Envista Holdings (NVST) | United States | $3.142B | 18.03 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.836B | 12.93 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| Perrigo (PRGO) | Ireland | $1.866B | 4.68 |
| Phibro Animal Health (PAHC) | United States | $1.826B | 18.24 |
| AtriCure (ATRC) | United States | $1.647B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.433B | 9.21 |
| Neogen (NEOG) | United States | $1.395B | 26.75 |
| Curaleaf Holdings (CURLF) | Canada | $1.345B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.291B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 18.29 |
| Green Thumb Industries (GTBIF) | United States | $1.186B | 52.00 |
| Tilray Brands (TLRY) | Canada | $1.157B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.156B | 343.00 |
| InMode (INMD) | Israel | $0.879B | 9.94 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.854B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| Omeros (OMER) | United States | $0.644B | 0.00 |
| Surmodics (SRDX) | United States | $0.612B | 0.00 |
| CeriBell (CBLL) | United States | $0.478B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.474B | 16.33 |
| Evolus (EOLS) | United States | $0.451B | 0.00 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| BillionToOne (BLLN) | $0.417B | 0.00 | |
| Cresco Labs (CRLBF) | United States | $0.319B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.297B | 50.60 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.280B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.260B | 0.00 |
| Quanterix (QTRX) | United States | $0.258B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.244B | 143.33 |
| Viemed Healthcare (VMD) | United States | $0.239B | 19.06 |
| High Tide (HITI) | Canada | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.224B | 2.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.223B | 0.00 |
| Organigram Global (OGI) | Canada | $0.201B | 0.00 |
| Exagen (XGN) | United States | $0.192B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 15.52 |
| FitLife Brands (FTLF) | United States | $0.165B | 20.35 |
| OraSure Technologies (OSUR) | United States | $0.161B | 0.00 |
| Apyx Medical (APYX) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.146B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.133B | 0.00 |
| Biote (BTMD) | United States | $0.118B | 5.16 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 12.96 |
| Sharps Technology (STSS) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Nephros (NEPH) | United States | $0.058B | 41.77 |
| ImmuCell (ICCC) | United States | $0.044B | 18.89 |
| Jin Medical (ZJYL) | China | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.19 |
| Bonk (BNKK) | United States | $0.024B | 0.00 |
| Zynex (ZYXI) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Functional Brands (MEHA) | $0.003B | 0.00 | |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |